<s id="wsj_2098.1"> 35
1 	 0 	 N/N 	 1 	 Inc. Oncor
1 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 Inc. said
3 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 Gaithersburg said
5 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 Md. said
8 	 9 	 (S[dcl]\NP)/NP 	 1 	 it received
9 	 7 	 (S[dcl]\NP)/S[dcl] 	 2 	 received said
10 	 9 	 (S[dcl]\NP)/NP 	 2 	 approval received
10 	 11 	 (NP\NP)/NP 	 1 	 approval from
14 	 11 	 (NP\NP)/NP 	 2 	 Food from
14 	 12 	 NP[nb]/N 	 1 	 Food the
14 	 13 	 N/N 	 1 	 Food U.S.
17 	 11 	 (NP\NP)/NP 	 2 	 Administration from
17 	 12 	 NP[nb]/N 	 1 	 Administration the
17 	 13 	 N/N 	 1 	 Administration U.S.
17 	 16 	 N/N 	 1 	 Administration Drug
19 	 18 	 (S[to]\NP)/(S[b]\NP) 	 2 	 market to
22 	 19 	 (S[b]\NP)/NP 	 2 	 test market
22 	 20 	 NP[nb]/N 	 1 	 test a
22 	 21 	 N/N 	 1 	 test genetic
22 	 23 	 (NP\NP)/(S[dcl]\NP) 	 1 	 test that
22 	 24 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test will <XB>
22 	 25 	 S[b]\NP 	 1 	 test assist <XB>
24 	 23 	 (NP\NP)/(S[dcl]\NP) 	 2 	 will that
25 	 24 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 assist will
25 	 26 	 ((S\NP)\(S\NP))/NP 	 2 	 assist in
27 	 26 	 ((S\NP)\(S\NP))/NP 	 3 	 diagnosis in
27 	 30 	 (NP\NP)/NP 	 1 	 diagnosis of
29 	 26 	 ((S\NP)\(S\NP))/NP 	 3 	 treatment in
29 	 30 	 (NP\NP)/NP 	 1 	 treatment of
31 	 30 	 (NP\NP)/NP 	 2 	 leukemia of
34 	 30 	 (NP\NP)/NP 	 2 	 cancer of
34 	 33 	 N/N 	 1 	 cancer lymph
<\s>
<s id="wsj_2098.2"> 36
4 	 0 	 NP[nb]/N 	 1 	 test The
4 	 1 	 N/N 	 1 	 test B\/T
4 	 2 	 N/N 	 1 	 test gene
4 	 3 	 N/N 	 1 	 test rearrangement
4 	 5 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 test is
4 	 7 	 S[adj]\NP 	 1 	 test accurate <XB>
4 	 12 	 (S[ng]\NP)/NP 	 1 	 test diagnosing <XB>
5 	 11 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 is for
5 	 31 	 (S[dcl]\S[dcl])/NP 	 1 	 is said
7 	 5 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 accurate is
7 	 6 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 accurate more
7 	 8 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 accurate than
10 	 8 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 tests than
10 	 9 	 N/N 	 1 	 tests existing
12 	 11 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 diagnosing for
14 	 12 	 (S[ng]\NP)/NP 	 2 	 type diagnosing
14 	 13 	 NP[nb]/N 	 1 	 type the
14 	 15 	 (NP\NP)/NP 	 1 	 type of
14 	 18 	 (NP\NP)/S[dcl] 	 1 	 type whether
14 	 23 	 (NP\NP)/S[dcl] 	 1 	 type whether <XU>
16 	 15 	 (NP\NP)/NP 	 2 	 cancer of
19 	 20 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 it has
19 	 21 	 S[pt]\NP 	 1 	 it spread <XB>
20 	 18 	 (NP\NP)/S[dcl] 	 2 	 has whether
21 	 20 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 spread has
24 	 25 	 (S[dcl]\NP[thr])/NP 	 1 	 there is
25 	 23 	 (NP\NP)/S[dcl] 	 2 	 is whether
27 	 25 	 (S[dcl]\NP[thr])/NP 	 2 	 recurrence is
27 	 26 	 NP[nb]/N 	 1 	 recurrence a
27 	 28 	 (S[ng]\NP)/NP 	 1 	 recurrence following <XB>
29 	 28 	 (S[ng]\NP)/NP 	 2 	 treatment following
35 	 31 	 (S[dcl]\S[dcl])/NP 	 2 	 Turner said
35 	 32 	 N/N 	 1 	 Turner Oncor
35 	 33 	 N/N 	 1 	 Turner President
35 	 34 	 N/N 	 1 	 Turner Stephen
<\s>
<s id="wsj_2098.3"> 26
1 	 0 	 N/N 	 1 	 Turner Mr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Turner said
4 	 3 	 NP[nb]/N 	 1 	 test the
4 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test will
4 	 8 	 S[pss]\NP 	 1 	 test used <XB>
4 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test might <XU>
4 	 20 	 (S[b]\NP)/NP 	 1 	 test become <XU>
6 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 will said
6 	 5 	 (S\NP)/(S\NP) 	 2 	 will initially
7 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
8 	 7 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 used be
8 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 used in
10 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 conjunction in
10 	 11 	 (NP\NP)/NP 	 1 	 conjunction with
12 	 11 	 (NP\NP)/NP 	 2 	 biopsies with
15 	 11 	 (NP\NP)/NP 	 2 	 tests with
15 	 14 	 N/N 	 1 	 tests other
19 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 might said
19 	 18 	 (S\NP)/(S\NP) 	 2 	 might eventually
20 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 become might
22 	 20 	 (S[b]\NP)/NP 	 2 	 benchmark become
22 	 21 	 NP[nb]/N 	 1 	 benchmark the
22 	 23 	 (NP\NP)/NP 	 1 	 benchmark for
25 	 23 	 (NP\NP)/NP 	 2 	 analysis for
25 	 24 	 N/N 	 1 	 analysis tumor
<\s>
<s id="wsj_2098.4"> 16
1 	 0 	 N/N 	 1 	 Turner Mr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Turner said
4 	 3 	 NP[nb]/N 	 1 	 test the
4 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test will
4 	 7 	 S[pss]\NP 	 1 	 test shipped <XB>
5 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 will said
6 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
7 	 6 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 shipped be
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 shipped in
7 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 shipped to
10 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 days in
10 	 9 	 N/N 	 1 	 days 45
12 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 hospitals to
15 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 laboratories to
15 	 14 	 N/N 	 1 	 laboratories clinical
<\s>
<s id="wsj_2098.5"> 42
2 	 0 	 N/N 	 1 	 Wilson Dr.
2 	 1 	 N/N 	 1 	 Wilson Wyndham
2 	 14 	 (S[dcl]\NP)/S[dcl] 	 1 	 Wilson said
7 	 4 	 NP[nb]/N 	 1 	 specialist a
7 	 5 	 N/N 	 1 	 specialist cancer
7 	 6 	 N/N 	 1 	 specialist treatment
7 	 8 	 (NP\NP)/NP 	 1 	 specialist at
7 	 14 	 (S[dcl]\NP)/S[dcl] 	 1 	 specialist said
12 	 8 	 (NP\NP)/NP 	 2 	 Institute at
12 	 9 	 NP[nb]/N 	 1 	 Institute the
12 	 10 	 N/N 	 1 	 Institute National
12 	 11 	 N/N 	 1 	 Institute Cancer
16 	 15 	 NP[nb]/N 	 1 	 test the
16 	 17 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 test is
16 	 19 	 S[pss]\NP 	 1 	 test used <XB>
16 	 24 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 test is <XU>
16 	 26 	 (S[ng]\NP)/NP 	 1 	 test having <XU>
17 	 14 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
19 	 17 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 used is
19 	 18 	 (S\NP)/(S\NP) 	 2 	 used widely
19 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 used in
22 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 centers in
22 	 21 	 N/N 	 1 	 centers research
24 	 14 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
24 	 25 	 (S\NP)\(S\NP) 	 2 	 is n't
26 	 24 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 having is
26 	 30 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 having because
29 	 26 	 (S[ng]\NP)/NP 	 2 	 impact having
29 	 27 	 NP[nb]/N 	 1 	 impact a
29 	 28 	 N/N 	 1 	 impact major
31 	 32 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 it is
31 	 35 	 (S[adj]\NP)/PP 	 1 	 it useful <XB>
32 	 30 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 is because
34 	 33 	 ((S[adj]\NP)/(S[adj]\NP))/((S[adj]\NP)/(S[adj]\NP)) 	 3 	 occasionally only
35 	 32 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 useful is
35 	 34 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 useful occasionally
36 	 35 	 (S[adj]\NP)/PP 	 2 	 in useful
37 	 36 	 PP/(S[ng]\NP) 	 1 	 choosing in
40 	 39 	 (N/N)/(N/N) 	 2 	 effective most
41 	 37 	 (S[ng]\NP)/NP 	 2 	 treatment choosing
41 	 38 	 NP[nb]/N 	 1 	 treatment the
41 	 40 	 N/N 	 1 	 treatment effective
<\s>
<s id="wsj_2098.6"> 24
2 	 1 	 NP[nb]/N 	 1 	 test the
2 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test may
2 	 4 	 (S[b]\NP)/(S[to]\NP) 	 1 	 test prove <XB>
2 	 8 	 (S[adj]\NP)/PP 	 1 	 test sensitive <XB>
3 	 0 	 S/S 	 1 	 may But
3 	 23 	 (S[dcl]\S[dcl])\NP 	 1 	 may said
4 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 prove may
5 	 4 	 (S[b]\NP)/(S[to]\NP) 	 2 	 to prove
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
8 	 6 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 sensitive be
8 	 7 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 sensitive more
9 	 8 	 (S[adj]\NP)/PP 	 2 	 in sensitive
10 	 9 	 PP/(S[ng]\NP) 	 1 	 determining in
11 	 10 	 (S[ng]\NP)/S[qem] 	 2 	 whether determining
13 	 12 	 NP[nb]/N 	 1 	 tumor a
13 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 tumor has
13 	 15 	 S[pt]\NP 	 1 	 tumor spread <XB>
13 	 17 	 S[pt]\NP 	 1 	 tumor returned <XU>
14 	 11 	 S[qem]/S[dcl] 	 1 	 has whether
15 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 spread has
15 	 18 	 ((S\NP)\(S\NP))/NP 	 2 	 spread following
17 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 returned has
17 	 18 	 ((S\NP)\(S\NP))/NP 	 2 	 returned following
19 	 18 	 ((S\NP)\(S\NP))/NP 	 3 	 treatment following
22 	 21 	 N/N 	 1 	 Wilson Dr.
22 	 23 	 (S[dcl]\S[dcl])\NP 	 2 	 Wilson said
<\s>
<s id="wsj_2098.7"> 15
0 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 We do
0 	 3 	 (S[b]\NP)/S[qem] 	 1 	 We know <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 do n't
1 	 14 	 (S[dcl]\S[dcl])\NP 	 1 	 do said
3 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 know do
3 	 4 	 (S\NP)\(S\NP) 	 2 	 know yet
5 	 3 	 (S[b]\NP)/S[qem] 	 2 	 how know
6 	 5 	 (S[qem]/S[dcl])/(S[adj]\NP) 	 2 	 useful how
7 	 8 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 it 's
7 	 11 	 S[b]\NP 	 1 	 it be <XB>
8 	 5 	 (S[qem]/S[dcl])/(S[adj]\NP) 	 1 	 's how
9 	 8 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 going 's
10 	 9 	 (S[ng]\NP)/(S[to]\NP) 	 2 	 to going
11 	 10 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
13 	 14 	 (S[dcl]\S[dcl])\NP 	 2 	 he said
<\s>
<s id="wsj_2098.8"> 33
0 	 10 	 (S[dcl]\NP)/S[em] 	 1 	 Oncor projects
4 	 2 	 NP[nb]/N 	 1 	 developer a
4 	 3 	 N/N 	 1 	 developer six-year-old
4 	 5 	 (NP\NP)/NP 	 1 	 developer of
4 	 10 	 (S[dcl]\NP)/S[em] 	 1 	 developer projects
8 	 5 	 (NP\NP)/NP 	 2 	 tests of
8 	 6 	 N/N 	 1 	 tests genetic
8 	 7 	 N/N 	 1 	 tests medical
10 	 32 	 (S[dcl]\S[dcl])\NP 	 1 	 projects said
11 	 10 	 (S[dcl]\NP)/S[em] 	 2 	 that projects
14 	 12 	 NP[nb]/N 	 1 	 test the
14 	 13 	 N/N 	 1 	 test cancer
14 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test will
14 	 16 	 ((S[b]\NP)/(S[to]\NP))/NP 	 1 	 test help <XB>
15 	 11 	 S[em]/S[dcl] 	 1 	 will that
16 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 help will
17 	 16 	 ((S[b]\NP)/(S[to]\NP))/NP 	 3 	 it help
17 	 19 	 (S[b]\NP)/NP 	 1 	 it post <XB>
18 	 16 	 ((S[b]\NP)/(S[to]\NP))/NP 	 2 	 to help
19 	 18 	 (S[to]\NP)/(S[b]\NP) 	 2 	 post to
19 	 23 	 ((S\NP)\(S\NP))/NP 	 2 	 post during
22 	 19 	 (S[b]\NP)/NP 	 2 	 profit post
22 	 20 	 NP[nb]/N 	 1 	 profit its
22 	 21 	 N/N 	 1 	 profit first-ever
26 	 23 	 ((S\NP)\(S\NP))/NP 	 3 	 quarter during
26 	 24 	 NP[nb]/N 	 1 	 quarter the
26 	 25 	 N/N 	 1 	 quarter first
26 	 27 	 (NP\NP)/NP 	 1 	 quarter of
28 	 27 	 (NP\NP)/NP 	 2 	 1990 of
31 	 30 	 N/N 	 1 	 Turner Mr.
31 	 32 	 (S[dcl]\S[dcl])\NP 	 2 	 Turner said
<\s>
<s id="wsj_2098.9"> 30
1 	 0 	 NP[nb]/N 	 1 	 company The
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 company will
1 	 3 	 ((S[b]\NP)/PP)/NP 	 1 	 company charge <XB>
1 	 10 	 (S[dcl]\NP)/NP 	 1 	 company projects <XU>
2 	 29 	 (S[dcl]\S[dcl])\NP 	 1 	 will said
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 charge will
4 	 3 	 ((S[b]\NP)/PP)/NP 	 3 	 $ charge
5 	 4 	 N/N[num] 	 1 	 35 $
6 	 3 	 ((S[b]\NP)/PP)/NP 	 2 	 for charge
8 	 6 	 PP/NP 	 1 	 test for
8 	 7 	 NP[nb]/N 	 1 	 test a
10 	 29 	 (S[dcl]\S[dcl])\NP 	 1 	 projects said
12 	 10 	 (S[dcl]\NP)/NP 	 2 	 $ projects
12 	 11 	 N/N 	 1 	 $ about
12 	 15 	 (NP\NP)/NP 	 1 	 $ in
12 	 17 	 (NP\NP)/NP 	 1 	 $ from
12 	 20 	 (NP\NP)/NP 	 1 	 $ during
14 	 12 	 N/N[num] 	 1 	 million $
14 	 13 	 N/N 	 1 	 million 2
16 	 15 	 (NP\NP)/NP 	 2 	 revenue in
19 	 17 	 (NP\NP)/NP 	 2 	 test from
19 	 18 	 NP[nb]/N 	 1 	 test the
24 	 20 	 (NP\NP)/NP 	 2 	 months during
24 	 21 	 NP[nb]/N 	 1 	 months the
24 	 22 	 N/N 	 1 	 months first
24 	 23 	 N/N 	 1 	 months 12
24 	 25 	 (NP\NP)/NP 	 1 	 months of
26 	 25 	 (NP\NP)/NP 	 2 	 marketing of
28 	 29 	 (S[dcl]\S[dcl])\NP 	 2 	 he said
<\s>
